ECSP951464A - ANTAGONIC FACTORS TO THE RELEASE OF CORTICOTROPIN - Google Patents
ANTAGONIC FACTORS TO THE RELEASE OF CORTICOTROPINInfo
- Publication number
- ECSP951464A ECSP951464A ECSP951464A ECSP951464A EC SP951464 A ECSP951464 A EC SP951464A EC SP951464 A ECSP951464 A EC SP951464A EC SP951464 A ECSP951464 A EC SP951464A
- Authority
- EC
- Ecuador
- Prior art keywords
- factors
- corticotropin
- release
- antagonic
- crf
- Prior art date
Links
- 102400000739 Corticotropin Human genes 0.000 title abstract 2
- 101800000414 Corticotropin Proteins 0.000 title abstract 2
- 230000003042 antagnostic effect Effects 0.000 title abstract 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 title abstract 2
- 229960000258 corticotropin Drugs 0.000 title abstract 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los factores para la liberación corticotropina (CRF) antagónicos tienen la fórmula:donde las líneas punteadas, A1 B1 Y1 Z1 G1 R3 1 R4 1 R5 1 R6 1 R1 6 Y1 R11 1 son como están definidas en la memoria y los procesos para prepararlas. Estos compuestos y sus sales farmacéuticamente aceptables son provechosas para el tratamiento de CNS y de los desórdenes relacionados con el estrés.The antagonistic factors for corticotropin release (CRF) have the formula: where the dotted lines, A1 B1 Y1 Z1 G1 R3 1 R4 1 R5 1 R6 1 R1 6 Y1 R11 1 are as defined in the specification and the processes to prepare them. These compounds and their pharmaceutically acceptable salts are beneficial for the treatment of CNS and stress related disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951464 ECSP951464A (en) | 1995-06-08 | 1995-06-08 | ANTAGONIC FACTORS TO THE RELEASE OF CORTICOTROPIN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951464 ECSP951464A (en) | 1995-06-08 | 1995-06-08 | ANTAGONIC FACTORS TO THE RELEASE OF CORTICOTROPIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP951464A true ECSP951464A (en) | 1996-11-04 |
Family
ID=42042109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP951464 ECSP951464A (en) | 1995-06-08 | 1995-06-08 | ANTAGONIC FACTORS TO THE RELEASE OF CORTICOTROPIN |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP951464A (en) |
-
1995
- 1995-06-08 EC ECSP951464 patent/ECSP951464A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901905T2 (en) | 2- (P�rin-9-yl) -tetrahidrofuran-3,4-diol t�revleri. | |
| ES2150567T3 (en) | CORTICOTROPIN RELEASE FACTOR ANTAGONISTS. | |
| MX9307810A (en) | NON-AROMATIC HETERO CYCLES SUBSTITUTED WITH AMINOMETHYLENE. | |
| ES2128544T3 (en) | PYROLOPYRIMIDINES AS CRF ANTAGONISTS. | |
| AR003955A1 (en) | DERIVATIVES OF N- (INDOL-2-CARBONYL) -GLYCINAMIDES, PROCEDURE FOR THEIR OBTAINING AND COMPOSITIONS THAT CONTAIN THEM. | |
| ATE177099T1 (en) | DIAZABICYCLIC NEUROKININ ANTAGONISTS | |
| ATE253586T1 (en) | 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVE | |
| SV2002000289A (en) | ANTIGONISTS OF THE CORTICOTROPINE RELEASE FACTOR REF. PC10759 / 20117 / BB | |
| CO4290424A1 (en) | PIRAZOLOPIRIDINES, PYRROLOPYRIDIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCEDURES FOR ITS ADMINISTRATION AS AN ANTAGONIST OF THE CORTICO-TROPINE RELEASE FACTOR | |
| ECSP941104A (en) | DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| MX9702797A (en) | LINK AGENTS TO CD23. | |
| TR200100410T2 (en) | 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives. | |
| FI20105844L (en) | Pharmaceutical compositions for the treatment of diseases caused by IL-6 production | |
| SE9702564D0 (en) | New compounds | |
| ATE248852T1 (en) | STEROL DERIVATIVES FOR REGULATION OF MEIOSIS | |
| ATE283268T1 (en) | 2-ADAMANTYLETHYLAMINES AND THEIR USE IN THE TREATMENT OF ABNORMALITIES IN GLUTAMATE TRANSMISSION | |
| MX9305248A (en) | DIARILPIPERAZINOACETAMIDA COMPOUNDS. | |
| DK0538134T3 (en) | Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase | |
| DK0765320T3 (en) | Benzimidazolone derivatives with central dopaminergic activity | |
| NO20022470D0 (en) | pyrimidine | |
| DE69229339D1 (en) | CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PRODUCTION AND USE | |
| NO180334C (en) | Analogous Process for the Preparation of Therapeutically Active Difluorostatone Analogs | |
| DE69530988D1 (en) | BENZIMIDAZOLE DERIVATIVES WITH DOPAMINERIC EFFECT | |
| SE9702563D0 (en) | Compounds | |
| BR9612196A (en) | Substituted thiazolines |